1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.36%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-33.63%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-110.42%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-105.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-111.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-111.98%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-113.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.55%
Share reduction more than 1.5x MAXN's 38.96%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-14.46%
Reduced diluted shares while MAXN is at 39.27%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-367.05%
Negative OCF growth while MAXN is at 17.84%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-441.53%
Negative FCF growth while MAXN is at 17.80%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-61.76%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-36.20%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-35.97%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
86.97%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
91.25%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
85.82%
Positive 3Y OCF/share CAGR while MAXN is negative. John Neff might see a big short-term edge in operational efficiency.
-1185.23%
Negative 10Y net income/share CAGR while MAXN is at 52.76%. Joel Greenblatt sees a major red flag in long-term profit erosion.
54.60%
5Y net income/share CAGR similar to MAXN's 52.76%. Walter Schloss might see both on parallel mid-term trajectories.
65.83%
3Y net income/share CAGR 1.25-1.5x MAXN's 52.76%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-87.55%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-78.76%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-38.27%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.32%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
9.55%
Inventory growth well above MAXN's 17.63%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.14%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.71%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
4.40%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
53.13%
R&D growth drastically higher vs. MAXN's 48.69%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-9.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.